Compared with memantine and nonuse, use of cholinesterase inhibitors significantly slowed cognitive decline at follow-ups. (HealthDay News) — Cholinesterase inhibitors (ChEIs) are beneficial for ...

July 19, 2006 — Two studies shed new light on the role of cholinesterase inhibitors (ChEIs) in Alzheimer's disease (AD), and in those at risk for the disease. The first study reviewed published ...

Dementia with Lewy bodies is a type of dementia that is similar to both Alzheimer's disease and Parkinson's disease but studies on long-term treatments are lacking. A new study from Karolinska ...

There is currently no cure for dementia with Lewy bodies, which is the 2nd most common type of dementia. Researchers from the Karolinska Institutet have found that Alzheimer’s disease medications ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Clinical trials in Alzheimer disease (AD) generally allow participants to continue receiving concomitant medications, including cholinesterase inhibitors (ChEIs) and memantine, if the dose is stable.

For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

Cholinesterase inhibitors slow cognitive decline over 5 years in patients with dementia with Lewy bodies, outperforming both memantine and no treatment, and reduce mortality risk in the first year ...

There’s so much to process after an Alzheimer’s diagnosis. Whether it’s you or a loved one who has this disease, you’re likely working through piles of complicated information, an avalanche of ...

Alzheimer's disease is a progressive disease that triggers brain cell deterioration. Over time, this makes things like remembering, learning, controlling emotions, and even basic tasks difficult or ...